Computer-Aided Design and Biological Evaluation of Diazaspirocyclic D<sub>4</sub>R Antagonists.
Ontology highlight
ABSTRACT: Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra, resulting in motor dysfunction. Current treatments are primarily centered around enhancing dopamine signaling or providing dopamine replacement therapy and face limitations such as reduced efficacy over time and adverse side effects. To address these challenges, we identified selective dopamine receptor subtype 4 (D4R) antagonists not previously reported as potential adjuvants for PD management. In this study, a library screening and artificial neural network quantitative structure-activity relationship (QSAR) modeling with experimentally driven library design resulted in a class of spirocyclic compounds to identify candidate D4
SUBMITTER: Jones CAH
PROVIDER: S-EPMC11191600 | biostudies-literature | 2024 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA